AU2002213878A1 - Use of erythropoietin and the derivatives of the same for treating schizophrenia and related psychoses - Google Patents
Use of erythropoietin and the derivatives of the same for treating schizophrenia and related psychosesInfo
- Publication number
- AU2002213878A1 AU2002213878A1 AU2002213878A AU1387802A AU2002213878A1 AU 2002213878 A1 AU2002213878 A1 AU 2002213878A1 AU 2002213878 A AU2002213878 A AU 2002213878A AU 1387802 A AU1387802 A AU 1387802A AU 2002213878 A1 AU2002213878 A1 AU 2002213878A1
- Authority
- AU
- Australia
- Prior art keywords
- erythropoietin
- derivatives
- same
- treating schizophrenia
- related psychoses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10043457A DE10043457A1 (en) | 2000-09-04 | 2000-09-04 | Processes for treating schizophrenia and related psychoses, and using erythropoietin or erythropoietin derivatives to treat schizophrenia and related psychoses |
DE10043457.6 | 2000-09-04 | ||
PCT/EP2001/010198 WO2002020031A2 (en) | 2000-09-04 | 2001-09-04 | Use of erythropoietin and the derivatives of the same for treating schizophrenia and related psychoses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002213878A1 true AU2002213878A1 (en) | 2002-03-22 |
Family
ID=7654867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002213878A Abandoned AU2002213878A1 (en) | 2000-09-04 | 2001-09-04 | Use of erythropoietin and the derivatives of the same for treating schizophrenia and related psychoses |
Country Status (10)
Country | Link |
---|---|
US (1) | US20040009912A1 (en) |
EP (1) | EP1315515B1 (en) |
JP (1) | JP2004522696A (en) |
AU (1) | AU2002213878A1 (en) |
CY (1) | CY1107287T1 (en) |
DE (2) | DE10043457A1 (en) |
DK (1) | DK1315515T3 (en) |
ES (1) | ES2296819T3 (en) |
PT (1) | PT1315515E (en) |
WO (1) | WO2002020031A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1736481A1 (en) | 2005-05-13 | 2006-12-27 | Charite Universitätsmedizin-Berlin | Erythropoietin variants |
US9988427B2 (en) | 2005-05-13 | 2018-06-05 | Charite Universitaetsmedizen-Berlin | Erythropoietin variants |
US20070072795A1 (en) * | 2005-09-28 | 2007-03-29 | Anton Haselbeck | Treatment of neurodegenerative disorders |
RU2484836C2 (en) * | 2011-09-21 | 2013-06-20 | Александр Иванович Воронов | Method of treating schizophrenia |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5416071A (en) * | 1991-03-12 | 1995-05-16 | Takeda Chemical Industries, Ltd. | Water-soluble composition for sustained-release containing epo and hyaluronic acid |
JP3156236B2 (en) * | 1991-09-30 | 2001-04-16 | 雪印乳業株式会社 | Remedies for improving memory impairment |
DE19857609A1 (en) * | 1998-12-14 | 2000-06-15 | Hannelore Ehrenreich | Use of erythropoietin for the treatment of human cerebral ischemia |
HUP0201598A3 (en) * | 1999-04-13 | 2002-10-28 | Kenneth S Warren Inst Ossining | Pharmaceutical composition comprising erythropoietin for modulation of excitable tissue function and their use |
-
2000
- 2000-09-04 DE DE10043457A patent/DE10043457A1/en not_active Ceased
-
2001
- 2001-09-04 AU AU2002213878A patent/AU2002213878A1/en not_active Abandoned
- 2001-09-04 PT PT01982244T patent/PT1315515E/en unknown
- 2001-09-04 DE DE50113300T patent/DE50113300D1/en not_active Expired - Lifetime
- 2001-09-04 ES ES01982244T patent/ES2296819T3/en not_active Expired - Lifetime
- 2001-09-04 US US10/363,617 patent/US20040009912A1/en not_active Abandoned
- 2001-09-04 JP JP2002524514A patent/JP2004522696A/en active Pending
- 2001-09-04 WO PCT/EP2001/010198 patent/WO2002020031A2/en active IP Right Grant
- 2001-09-04 EP EP01982244A patent/EP1315515B1/en not_active Expired - Lifetime
- 2001-09-04 DK DK01982244T patent/DK1315515T3/en active
-
2008
- 2008-02-21 CY CY20081100211T patent/CY1107287T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1315515A2 (en) | 2003-06-04 |
DK1315515T3 (en) | 2008-04-14 |
PT1315515E (en) | 2008-03-03 |
WO2002020031A3 (en) | 2002-08-01 |
DE10043457A1 (en) | 2002-03-28 |
ES2296819T3 (en) | 2008-05-01 |
EP1315515B1 (en) | 2007-11-21 |
DE50113300D1 (en) | 2008-01-03 |
WO2002020031A2 (en) | 2002-03-14 |
US20040009912A1 (en) | 2004-01-15 |
CY1107287T1 (en) | 2012-11-21 |
JP2004522696A (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5056300A (en) | Devices and compounds for treating arterial restenosis | |
AU2002224927A1 (en) | Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds | |
AU2002338336A1 (en) | Epothilone derivatives and methods for making and using the same | |
AU2002360089A1 (en) | Polymer derivatives for treating metals | |
AU2001219185A1 (en) | 2-acylaminobenzimidazole derivatives for treating glaucoma | |
AU2002217866A1 (en) | Geldanamycin derivatives useful for the treatment of cancer | |
AU4501199A (en) | 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors | |
AU3814599A (en) | Use of erythropoietin for the treatment of haemochromatoses | |
AU2002213878A1 (en) | Use of erythropoietin and the derivatives of the same for treating schizophrenia and related psychoses | |
AU2002338989A1 (en) | Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives | |
AU2001255580A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2002216939A1 (en) | Quinoline derivatives and their use as anti-epileptics | |
AU2001225523A1 (en) | Novel arylpropionaldehyde derivatives and production and use of the same | |
AU2002217915A1 (en) | Compositions and methods for diagnosing or treating psoriasis | |
AU2002229859A1 (en) | Chemical derivatives and their use as anti-telomerase agent | |
AU2002227952A1 (en) | Klainetin and derivatives thereof, method for their production and the use of the same | |
AU2002347393A1 (en) | Susceptibility locus for schizophrenia | |
HUP9900123A3 (en) | 1-isothiazolidinone derivatives of azetidine-2-one, processes for the preparation thereof and use thereof | |
AU2795202A (en) | Klainetin and derivatives thereof, method for their production and the use of the same | |
AU2001257164A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2002366756A1 (en) | Use of benzofuroxan derivatives as antiplatelet agents | |
AU2002336130A1 (en) | Pyridin-2-YL-Methlyamine derivatives for treating opioid dependence | |
AU2001259127A1 (en) | Methods and composition for the diagnosis of schizophrenia | |
AU2001255597A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2001257179A1 (en) | Methods and compositions for the diagnosis of schizophrenia |